Keywords: ec, clears, roche, tarceva, pancreatic, cancer, swiss

EC clears Roche's Tarceva in pancreatic cancer

Article | 05 February 2007

Print This

Swiss drug major Roche's Tarceva (erlotinib) has been approved by the European Commission for the treatment of patients with metastatic ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in